Literature DB >> 34935123

MiR-194-3p modulates the progression of colorectal cancer by targeting KLK10.

Tao Liu1, Yuejun Fang2.   

Abstract

BACKGROUND: A rich history of studies have manifested the importance of miRNAs to cancer progression, while miR-194-3p has been seldom explored.
OBJECTIVE: The purpose of this study is to unearth the way the KLK10/miR-194-3p axis modulates colorectal cancer (CRC).
METHODS: Differentially expressed genes of CRC in TCGA database were analyzed. Western blot and qRT-PCR were employed to test protein and mRNA expressions of two researched genes. Their targeting was confirmed using dual-luciferase. Biological behaviors of cells were tested by a series of cellular functional assays. RESULT: Remarkably low miR-194-3p expression and high KLK10 expression were observed in cancer cells. Overexpressing miR-194-3p hindered the progression of CRC cells. Overexpression of miR-194-3p significantly weakened the promoting effect of upregulated KLK10 on cell migration, invasion and proliferation. Their targeting was verified by dual -luciferase assay. Therefore, miR-194-3p hindered cell behaviors of CRC through KLK10.
CONCLUSION: This investigation casts new light on the treatment of CRC through the KLK10/miR-194-3p axis.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34935123     DOI: 10.14670/HH-18-413

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  29 in total

1.  Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.

Authors:  Gholam Basati; Amirnader Emami Razavi; Iraj Pakzad; Fardin Ali Malayeri
Journal:  Tumour Biol       Date:  2015-08-29

Review 2.  MicroRNAs in colorectal cancer metastasis.

Authors:  Inge de Krijger; Leonie J M Mekenkamp; Cornelis J A Punt; Iris D Nagtegaal
Journal:  J Pathol       Date:  2011-06-27       Impact factor: 7.996

3.  Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.

Authors:  Bo Feng; Wei-Bin Xu; Min-Hua Zheng; Jun-Jun Ma; Qu Cai; Yi Zhang; Jun Ji; Ai-Guo Lu; Ying Qu; Jian-Wen Li; Ming-Liang Wang; Wei-Guo Hu; Bing-Ya Liu; Zheng-Gang Zhu
Journal:  J Gastroenterol Hepatol       Date:  2006-10       Impact factor: 4.029

Review 4.  The emerging roles of human tissue kallikreins in cancer.

Authors:  Carla A Borgoño; Eleftherios P Diamandis
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

Review 5.  The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment.

Authors:  Louise C Connell; José Mauricio Mota; Maria Ignez Braghiroli; Paulo M Hoff
Journal:  Curr Treat Options Oncol       Date:  2017-04

Review 6.  MicroRNAs in cancer.

Authors:  Yong Sun Lee; Anindya Dutta
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

7.  microRNA-192, -194 and -215 are frequently downregulated in colorectal cancer.

Authors:  Yeunpo Chiang; Yongxi Song; Zhenning Wang; Zhuangkai Liu; Peng Gao; Jiwang Liang; Jinliang Zhu; Chengzhong Xing; Huimian Xu
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

8.  Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.

Authors:  Hsin-Yi Chang; Shu-Ping Ye; Shiow-Lin Pan; Tzu-Ting Kuo; Bia Chia Liu; Yi-Lin Chen; Tsui-Chin Huang
Journal:  Theranostics       Date:  2017-09-05       Impact factor: 11.556

9.  MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasis.

Authors:  Hong-Ke Cai; Xi Chen; Yun-Hao Tang; Yong-Chuan Deng
Journal:  Onco Targets Ther       Date:  2017-02-28       Impact factor: 4.147

Review 10.  The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention.

Authors:  Hermann Brenner; Chen Chen
Journal:  Br J Cancer       Date:  2018-10-04       Impact factor: 7.640

View more
  1 in total

1.  The role of miR-4469 as a tumor suppressor regulating inflammatory cell infiltration in colorectal cancer.

Authors:  Lu Qi; Lu Wang; Fuyao Song; Zhenhua Ding; Ying Zhang
Journal:  Comput Struct Biotechnol J       Date:  2022-07-14       Impact factor: 6.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.